Latest Cutaneous lupus erythematosus Stories
Hundreds Step Up For New Lupus Treatments NEW YORK, Sept.
A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged.
HERZLIYA, Israel, July 16, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd.
--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, July 16, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of a multi-dose, one month
Strengthens Collaboration between the Nation's Lupus Research Organizations NEW YORK, July 8, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) today announced that Team
A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that, for the majority of lupus patients who are in remission, it is possible to successfully stop immunosuppressant therapy without triggering a flare of their disease.
Raises Thousands to Fund Research and Support for Lupus Community NEW YORK, June 11, 2014 /PRNewswire/ -- The
NEW YORK, June 10, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) launched the LRI Industry Council,
CHICAGO, June 9, 2014 /PRNewswire-USNewswire/ -- Bruce Richardson, M.D., Ph.D., of The University of Michigan, has been selected as the second recipient of the Lupus Insight Prize.
ALBUQUERQUE, N.M., June 9, 2014 /PRNewswire/ -- Exagen Diagnostics, Inc., a leading medical diagnostic company focused in rheumatology, today announced the addition of the Avise SLE Prognostic
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).